HLA-E and ovarian carcinoma: Multiple solid and haematological malignancies have been observed to over-express HLA-E and associations between high HLA-E expression and worse clinical outcome have been reported in cancers including ovarian carcinoma, glioblastoma, gastric cancer and multiple myeloma [43,44,45,46].